Spots Global Cancer Trial Database for ePRO for the Timely Detection of Side Effects in Cancer Patients Undergoing CAR T Immunotherapy
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: ePRO for the Timely Detection of Side Effects in Cancer Patients Undergoing CAR T Immunotherapy
Official Title: ePRO for the Timely Detection of Side Effects in Cancer Patients Undergoing CAR T Immunotherapy: Feasibility Study (CARTePRO)
Study ID: NCT05354973
Interventions
Study Description
Brief Summary: This study is designed as a feasibility study implementing electronic Patient Reported Outcomes (ePRO) in CAR T treatment for hematological malignancies, in order to describe AE reporting. ePRO assessments will be explored for their feasibility to engage in monitoring and management of CAR T-related toxicities as well as using these digital ePRO tools may improve both, its safety and accessibility.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Klinik für Hämatologie und Onkologie, Zürich, , Switzerland
Contact Details
Name: Panagiotis Samaras, PD.Dr.med
Affiliation: Klinik für Hämatologie und Onkologie
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
